Asthma Clinical Trial
Official title:
Head-Off Environmental Asthma in Louisiana
This study will examine whether exposure to the increased levels of mold and other allergens
in New Orleans post-Hurricane Katrina affect symptoms in children with asthma. It will also
determine if having an asthma counselor (AC) can reduce a child s asthma symptoms in this
setting. An AC helps the families in the study obtain appropriate health care, medicines and
social services for their asthmatic child and instructs them about avoiding allergens and
ridding allergens from the home.
Children between 4 and 12 years of age living in Orleans Parish or surrounding areas impacted
by flooding who have moderate to severe asthma may be eligible for this study.
Parents provide a family medical history and information about the child s asthma symptoms,
medications and medical history. The children undergo the following procedures:
- Medical examination and blood tests
- Spirometry (for children 6 and older) or peak flow (for children under 6) test: For
spirometry, the child wears a nose clip and breathes into a mouthpiece attached to a
machine that measures how fast air moves out of the child s lungs. For the peak flow
meter test, the child blows into a plastic tube after taking a deep breath.
- Allergy skin testing: 24 common allergens are applied to the arm by little pricks or
scratches and the skin is observed for reactions to the allergens.
Study staff visit the participants homes three times during the 1-year study to test for
moisture, mold and other allergens. After the first visit, families are randomly assigned to
one of two groups. Group 1 participants attend two educational group sessions about asthma
and then three individual sessions. An AC visits the home one time during the study to
instruct the family on how to use supplies provided to reduce allergens in the home. Group 2
participants have an individual special teaching meeting with the AC at the end of the study.
After the meeting, the AC visits the home to instruct the family on use of the supplies.
Families are surveyed by phone every 3 months during the study to answer questions about the
child s asthma attacks, medicines used, doctor visits, school days, missed, or work days
missed to care for the child. At the end of the study, the child has a final medical
examination, blood test, and breathing test.
This document presents the protocol for conducting the Head-off Environmental Asthma in
Louisiana (HEAL) study in New Orleans, Louisiana. The goal of the HEAL study is to implement
and test an Asthma Counselor (AC) intervention program that addresses the multidimensional
impact of hurricane Katrina on children with asthma in New Orleans. HEAL is a prospective,
controlled trial in which children will be randomly assigned to one of two treatment groups.
Group 1 children will receive an AC intervention focused on case management, adherence to
medications and education on allergen avoidance. The responsibilities of the AC in this study
are enhanced relative to previous initiatives such as the National Cooperative Inner City
Asthma Study (NCICAS) AC intervention to also provide families with education aimed at
reducing mold, allergens, and moisture in their homes, and materials to aid this effort
(dehumidifiers and HEPA air filters). Since 90% of children with asthma in New Orleans are
sensitive to dust allergens, established allergen control measures will be incorporated into
the AC intervention as well. Group 2 children will receive a high quality standard of care
based on the National Asthma Education and Prevention Program (NAEPP)-NIH guidelines. An
abbreviated AC intervention will be provided to children in Group 2 at the conclusion of the
study. Both treatments will be administered over a 12-month period during which the children
in both groups will receive an extensive clinical evaluation (at baseline and 12-months) and
three environmental home evaluations (focused on moisture, mold and other allergens). In
addition to monitoring the effectiveness of the AC at environmental remediation education,
the environmental home evaluations will also allow some characterization of the relationships
between allergens, post-Katrina environmental exposures and asthma morbidity.
In addition to the enhanced AC intervention, a separate school based survey will be
administered to a sample population of children to examine asthma prevalence and assess
living conditions and stress levels that may have been influenced by hurricane Katrina. The
survey population will consist of a sample of the families of Orleans Parish school children
stratified by age, schools and geographic area of the Parish. The results of the survey, in
combination with the results of the AC intervention, will give us an overview of the extent
and severity of the asthma problem in post hurricane Katrina New Orleans.
The HEAL project is a collaborative multi-institutional research project conducted by the
Tulane University School of Public Health and Tropical Medicine and the New Orleans
Department of Health. To support those efforts, Rho, Inc. will provide for coordination of
data and study activities.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|